Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Percy Ivy

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigationHeekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer SubjectsAaron S Mansfield, Michelle A Rudek, Diana Vulih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to M. Voskoboynik et alDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal of the National Cancer Institute|September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsAndrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigationHeekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer SubjectsAaron S Mansfield, Michelle A Rudek, Diana Vulih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to M. Voskoboynik et alDavid M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Challenges and Opportunities in Adapting Clinical Trial Design for ImmunotherapiesLillian L Siu, S Percy Ivy, Erica L Dixon, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.
Journal of the National Cancer Institute|September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsAndrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Pageof 15